SLCO1A2 and breast carcinoma: Silencing of SLCO1A2 did not affect DOX mediated cell death in BT549 breast cancer cells at reported circulating (Fig. 4a) or even at lower (Supplementary Fig. 8) concentrations, suggesting that other key transporters may mediate DOX-related cell death in BT549 breast cancer cells44.